Publications

Healthcare
Insights

In our most recent case studies, market research reports, conference talks, and other publications, we share and visualize our market insights.

Get In Touch Press Requests LinkedIn

Spotlight

6 Insights on “PECAN” by Vincent Erdmann

14. September 2023

In "6 Insights on PECAN" our PECAN expert Vincent Erdmann answers the most relevant questions of the PECAN process in France.

7 Insights on DiGA by Alexander Voigt

1. September 2023

In "7 Insights on DiGA", our DiGA expert Alexander Voigt provides answers to the most relevant questions about DiGA.

DiGA in Pharma: Everything You Need To Know Now.

14. April 2023

In an extensive article in PM-Report, Germany's most significant pharma magazine, Digital Oxygen's experts provide a 360° overview of DiGA in the context of pharma.

6 Insights on “PECAN” by Vincent Erdmann

14. September 2023/in DiGA, DiGA, DiGA Wissen, DiGA Wissen, General, PECAN, PECAN/by Ludwig Thiede

In “6 Insights on PECAN” our PECAN expert Vincent Erdmann answers the most relevant questions of the PECAN process in France.

9 Insights on Sales Force Performance Boost

6. September 2023/in General/by Ludwig Thiede

In “9 Insights on Sales Force Performance Boost”, our partner Torsten Christann answers the most relevant questions about the Sales Boost and its benefits for companies.

7 Insights on DiGA by Alexander Voigt

1. September 2023/in DiGA, DiGA Wissen/by Ludwig Thiede

In “7 Insights on DiGA”, our DiGA expert Alexander Voigt provides answers to the most relevant questions about DiGA.

8 Insights on Prequalification

24. August 2023/in General/by Ludwig Thiede

In “8 Insights on Prequalification”, our expert Dr. Sigrid Bender answers the most relevant questions about the prequalification process.

Insights on DiGA Fast Track and the Future of Digital Health

13. July 2023/in DiGA Wissen, General/by Ludwig Thiede

In a recent interview, Alexander Voigt discussed the success of Germany’s DiGA Fast Track program, the challenges faced by digital care applications, and the future of digital health in Germany.

DiPA in a Nutshell

4. July 2023/in DiPA, General/by Ludwig Thiede

Great news for Digital Health in Germany: After DiGA, Digital Care Applications (=DiPA) are now also coming into the care sector.

PECAN – The French DiGA Fast-Track

22. May 2023/in General/by Ludwig Thiede

With our expertise in DiGA approval and our international network, we support our customers in all issues related to the PECAN process.

DiGA in Pharma: Everything You Need To Know Now.

14. April 2023/in DiGA, DiPA/by diox_admin

In an extensive article in PM-Report, Germany’s most significant pharma magazine, Digital Oxygen’s experts provide a 360° overview of DiGA in the context of pharma.

Digital Health Due Diligence

15. March 2023/in Digital Health Due Diligence/by Ludwig Thiede

Our clients have a plethora of options when it comes to engaging with digital health providers.

Advanced Diabetes Technology Landscape 2023

20. February 2023/in Diabetes Technologie, Diabetes Technology/by diox_admin

The Advanced Diabetes Technology Landscape 2023 is an extensive overview of companies shaping the future of diabetes care.

6G and Digital Health

10. February 2023/in DiGA, General/by diox_admin

There are high hopes that 6G will revolutionize digital health. Axel Meiling provides insights why 6G per se won’t be the solution – and what the actual blockers for digital health are.

DiGA Iceberg: The unknown number of DiGA prescriptions

7. February 2023/in DiGA/by Ludwig Thiede

One aspect of DiGA is frequently left out in recent reports: The unknown number of DiGA prescriptions – the part of the DiGA iceberg that is not visible.

Healthcare Equality – Panel Talk at Med-Tech-World

31. January 2023/in General/by Ludwig Thiede

At the panel discussion at this year’s Med-Tech World in Malta, the question was discussed: Does digitalization succeed in creating health equality?

DiPA Canvas 2023

16. January 2023/in DiPA, DiPA, DiPA, General/by diox_admin

With the DiPA Canvas, Digital Oxygen provides a straight-forward tool for the self-assessment of essential questions for any DiPA manufacturer.

DiGA Canvas 2023

1. January 2023/in DiGA, DiPA/by diox_admin

The DiGA Canvas is a comprehensive tool to assess the crucial questions, challenges, and requirements for your DiGA.

Pharma and the 4D – Opportunity or Threat?

16. November 2022/in DiGA/by diox_admin

In this article, Torsten Christann comments on the importance, opportunities, and downsides of data for the pharma industry’s future business models.

Advanced Diabetes Technology Landscape 2022

1. November 2022/in Diabetes Technologie, Diabetes Technology/by diox_admin

The Advanced Diabetes Technology Landscape 2022 gives a structured overview of the companies shaping the future of Diabetes Care.

DiGA Partnerships: Start-ups Meet Corporates

5. October 2022/in DiGA/by diox_admin

There is a trend of DiGA start-ups looking for corporate partners and vice versa. But why?

Digital Health Due Diligence (Whitepaper)

1. August 2022/in Digital Health Due Diligence/by diox_admin

Our case study and framework showcases the relevant dimensions and questions to be asked when considering a DiGA acquisition.

Self-Measurement as Opportunity for Real-World-Evidence in Market Access

26. May 2022/in DiGA/by diox_admin

Sensors, wearables, apps: Torsten Christann comments on the opportunities of self-measurement for the generation of Real-World-Evidence in Market Access processes.

Apps On Prescription and Big Pharma: A Beneficial Combination?

26. May 2022/in DiGA, DiGA/by diox_admin

In this article, Torsten Christann addresses the question whether pharma corporations should add DiGA to their portfolio or no.

Enduring DiGA Success: Reaching Patients After Market Access

5. May 2022/in DiGA/by diox_admin

At WIG2 Digital Health Conference, Healthcare Expert Alexander Voigt talked about what matters after the regulatory market access: Reaching patients.

Connected Diabetes Care in Hospitals (Case Study)

1. February 2022/in Diabetes Technology/by diox_admin

This study examines the pain points and inefficiencies of diabetes care in German hospitals – and how there is a case for Glucometry MedTechs to disrupt the industry.